StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV)

StockNews.com initiated coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research report report published on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Performance MNOV opened at $1.82 on Thursday. MediciNova has a fifty-two week low of $1.12 and a fifty-two week high of $2.38. The […]

Leave a Reply

Your email address will not be published.

Previous post Roth Mkm Reiterates Buy Rating for Mama’s Creations (NASDAQ:MAMA)
Next post Western Copper & Gold (NYSE:WRN) Upgraded at StockNews.com